 Connection
Sean O'Leary to Serogroup
This is a "connection" page, showing publications Sean O'Leary has written about Serogroup.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.093 |
|
|
|
-
Rhodes JC, Kahn R, Bolcen S, Shang N, Chung Y, Farley MM, Britton AN, Moore AE, Thomas S, Nadle J, Amsden LB, Skarbinski J, VanWinden KR, Barnes M, Engesser K, Ferrieri P, Hansen AP, Harrison LH, Jeffrey L, Nyholm JL, O'Leary ST, Olson-Chen C, Rowlands JV, Seopaul SA, Thomas AR, Wrigley HHN, McGee L, Vishwanathan SA, Akhter F, Alston B, Jia LT, Li Y, Patel PY, Rivers J, Southwell JE, Tran T, Maniatis P, Schrag SJ. A US case-control study to estimate infant group B streptococcal disease serological thresholds of risk-reduction. Nat Commun. 2025 Oct 23; 16(1):9381.
Score: 0.058
-
Kempe A, Allison MA, MacNeil JR, O'Leary ST, Crane LA, Beaty BL, Hurley LP, Brtnikova M, Lindley MC, Albert AP. Adoption of Serogroup B Meningococcal Vaccine Recommendations. Pediatrics. 2018 09; 142(3).
Score: 0.035
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|